Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06537778Completed
Randomised, double-blind trial in Spontaneous Preterm Birth (SPB) comparing Atosiban with Placebo (2 arms). Primary endpoint: Rate of spontaneous Preterm Birth up to 34 weeks. Started Jan 2018; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06537778.